Journal of Medicinal Chemistry p. 466 - 472 (1988)
Update date:2022-07-29
Topics: In vitro Derivatives Antagonists in vivo High-Throughput Screening Pharmacokinetics Experimental terms Assay Platelet Activating Factor Pharmacodynamics
Tilley, Jefferson W.
Burghardt, Barbara
Burghardt, Charles
Mowles, Thomas F.
Leinweber, Franz-Josef
et al.
A series of N-<(heteroaryl)alkyl>pyrido<2,1-b>quinazolines were evaluated for their ability to inhibit the binding of radiolabeled platelet activating factor (PAF) to its receptor on dog platelets.The most potent compounds in this series were found to be
View Morewebsite:https://www.yurisolar.com/en
Contact:86--18092602675
Address:No. 560, East Hangtian Road, Xi'an, China
hangzhou sunchem trading co., ltd.
Contact:13588470430--
Address:Room 406-407, the 4th Building, No549
Zhushan County Tianxin Pharmaceutical & Chemical Co., Ltd.
Contact:0086-719-4224892
Address:Tutang Road, Chengguan Town, Zhushan County, Hubei Province
Contact:+86-571-87859231, 87859237, 87859239
Address:1606,Huarong Times Mansion, No.3880 Jiangnan Avenue, Binjiang District, Hangzhou, China, 310053
Beijing Mesochem Technology Co.,LTD
website:http://www.mesochem.com
Contact:0086-10-57862036
Address:2301, Floor 23, Building 9 Lippo Plaza, Yard 8 Ronghua Middle Road, ETDZ, Beijing, China
Doi:10.1021/jo00238a021
(1988)Doi:10.1021/ja01574a048
(1957)Doi:10.1039/c39830001082
(1983)Doi:10.1021/jo00238a041
(1988)Doi:10.1021/jo00249a001
(1988)Doi:10.1016/j.ejmech.2008.03.019
(2009)
